Cite
Prevalence and Prognostic Significance of Hypertrophic Cardiomyopathy Phenotype in PKP2-Mediated Arrhythmogenic Cardiomyopathy.
MLA
castrichini, Matteo, et al. “Prevalence and Prognostic Significance of Hypertrophic Cardiomyopathy Phenotype in PKP2-Mediated Arrhythmogenic Cardiomyopathy.” Journal of Cardiac Failure, vol. 30, Sept. 2024, p. S14. EBSCOhost, https://doi.org/10.1016/j.cardfail.2024.08.029.
APA
castrichini, M., Garmany, R., Neves, R. A. L., Siontis, K., Newman, D., Geske, J., Ommen, S., Schneider, J., Cooper, L., Ackerman, M., & Giudicessi, J. (2024). Prevalence and Prognostic Significance of Hypertrophic Cardiomyopathy Phenotype in PKP2-Mediated Arrhythmogenic Cardiomyopathy. Journal of Cardiac Failure, 30, S14. https://doi.org/10.1016/j.cardfail.2024.08.029
Chicago
castrichini, Matteo, Ramin Garmany, Raquel Almeida Lopes Neves, Konstantinos Siontis, Darrell Newman, Jeffrey Geske, Steve Ommen, et al. 2024. “Prevalence and Prognostic Significance of Hypertrophic Cardiomyopathy Phenotype in PKP2-Mediated Arrhythmogenic Cardiomyopathy.” Journal of Cardiac Failure 30 (September): S14. doi:10.1016/j.cardfail.2024.08.029.